MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells through SNAI2-Mediated GSK-3β/β-Catenin Pathway

Figure 5

MiR-429 involved in the inactivation of GSK-3β/β-catenin via targeting SNAI2. (a) The relative expression level of SNAI2. (b–f) The protein expression levels of SNAI2, β-catenin, p-GSK-3β, and GSK-3β. meant .

(a)

(b)

(c)

(d)

(e)

(f)